The Feasibility of Simplified Telephone Follow-up After Medical Abortion

NCT ID: NCT00619658

Last Updated: 2016-01-28

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 139 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2008-02-29
• Study Completion Date: 2009-08-31

Brief Summary

To assess the feasibility of using simplified telephone follow-up to predict pregnancy expulsion after medical abortion, and if in-person follow-up is required to determine the percentage of women that will present for that follow-up.

Detailed Description

This is a prospective trial to evaluate the feasibility of performing a telephone interview to predict if pregnancy expulsion has occurred. In those women for whom expulsion has not been predicted to have occurred, the trial will evaluate if they will present for a follow-up visit. We plan to recruit 154 women that desire a medical abortion from Magee-Womens Hospital, Planned Parenthood of Western Pennsylvania, and private offices in the surrounding area. Women who are no more than 63 days gestation will receive mifepristone 200mg and misoprostol 800mcg. Each subject will choose between two evidence-based methods of using the misoprostol: buccally 24-72 hours or vaginally 0-72 hours after mifepristone. A follow-up phone call with a clinician will occur 5-9 days after mifepristone administration. Based on clinical history, including a structured question set, the subject and the clinician will predict if expulsion occurred. If either or both feel that expulsion may not have occurred, the women will return for follow-up in the office within one week for sonographic evaluation. If they both predict that expulsion has occurred at this initial phone call follow-up, the subject will perform a urine pregnancy test at home in approximately 3 weeks. She will have a follow-up phone call after the pregnancy test to obtain the results. The subject will only have an additional visit and ultrasound examination if the urine pregnancy test is positive.

The primary outcome is the percentage of women that will be available for follow-up over the phone, and/or return visit if necessary. The secondary outcomes are to determine if a standardized set of questions of clinical history after medical abortion will be useful to predict expulsion of the pregnancy and which mode of misoprostol administration women prefer. In addition, the study will confirm if women and clinicians are accurate at predicting expulsion of the pregnancy, compare the ability of patients and clinicians to predict expulsion of the pregnancy, determine how many women require follow-up evaluation after a telephone interview, and to determine the pregnancy continuation rate after misoprostol and mifepristone in this study.

Conditions

Induced Abortion

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

1

All women undergoing medical abortion will have telephone follow-up approximately one week after using mifepristone and misoprostol.

Group Type: EXPERIMENTAL

telephone follow-up

Intervention Type: OTHER

subjects undergoing medical abortion will recieve a telephone call and be asked a series of clinical questions. Expulsion of the pregnancy will be assessed based on the answers to those questions.

Interventions

telephone follow-up

subjects undergoing medical abortion will recieve a telephone call and be asked a series of clinical questions. Expulsion of the pregnancy will be assessed based on the answers to those questions.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• healthy females
• requesting an elective termination of pregnancy by medical abortion
• an intrauterine pregnancy </= 63 days gestation
• willing and able to sign the informed consent
• willing to comply with the study protocol and visit schedule
• willing to have a surgical abortion/D&C if indicated
• with easy and ready access to a telephone

Exclusion Criteria

• contraindication to mifepristone
• contraindication to misoprostol
• cardiovascular disease -hemoglobin <10 g/dL
• known clotting defect or receiving anticoagulants
• pregnancy with an IUD
• breastfeeding
• ultrasound evidence of an early pregnancy failure
• pelvic examination with evidence of acute cervicitis
• prior participation in this research study
• current participation in a conflicting research study

• Minimum Eligible Age: 18 Years
• Eligible Sex: FEMALE
• Accepts Healthy Volunteers: Yes

Sponsors

University of Pittsburgh

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Lisa K Perriera, MD

Role: PRINCIPAL_INVESTIGATOR

Center for Family Planning Research, University of Pittsburgh

Locations

Center for Family Planning Research, Magee-Womens Hospital, University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States

Countries

United States

References

Rossi B, Creinin MD, Meyn LA. Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion. Contraception. 2004 Oct;70(4):313-7. doi: 10.1016/j.contraception.2004.04.005.

Reference Type: BACKGROUND

PMID: 15451336 (View on PubMed)

Related Links

http://www.birthcontrolstudies.org

Center for Family Planning Research website

Other Identifiers

PRO07080379

Identifier Type: -

Identifier Source: org_study_id